About the conference

25th International Conference on Gastroenterology and Hepatology
Date: June 04-05, 2025
Location: Edinburgh, Scotland
Theme: "Innovations in Gastroenterology and Hepatology: Bridging Research with Patient Care"

The 25th International Conference on Gastroenterology and Hepatology promises a distinctive convergence of leading experts, pioneering researchers, and key decision-makers from across the globe. Held in the historic and intellectually vibrant city of Edinburgh, this event stands out as a premier platform for translating research into actionable clinical advancements. With a focus on cutting-edge innovations and multidisciplinary collaboration, the Gastroenterology Conference 2025 will delve into transformative topics such as precision medicine, advanced endoscopy techniques, Liver disease, novel therapeutic interventions, and the integration of AI in diagnostics and treatment. The program is designed to foster thought-provoking discussions through keynote speeches, specialized workshops, and collaborative forums, ensuring attendees leave equipped with actionable insights.

What sets this Gastroenterology Conference apart is its commitment to bridging the gap between bench-side discoveries and bedside applications, fostering a meaningful dialogue between academia, clinical practice, and the healthcare industry.

Join us in shaping the future of gastroenterology and hepatology while experiencing Edinburgh’s dynamic cultural heritage!

Why to attend

The Gastroenterology Conference, scheduled for June 4-5, 2025, in Edinburgh, Scotland. This landmark event, organized by Conference Series—a worldwide leader in organizing prestigious scientific conferences—brings together an unparalleled network of medical experts, analysts, and industry leaders committed to advancing the fields of digestive and liver health. Conference Series is committed to giving a global stage for scientific learning and collaboration. With a portfolio of over 3,000 annual conferences over different areas, Conference Series facilitates information exchange among researchers, analysts, and healthcare experts around the world.

Benefits for Attendees:

• Elite Access to Pioneering Research: Participants will gain exclusive experiences into new strategies, treatments, and developing studies that are shaping patient care and clinical practice worldwide.
• High-Caliber Keynote Speakers: Learn directly from the industry’s best. Our keynote sessions highlight eminent experts who will cover a range of topics, from innovative approaches to treating digestive disorders to understanding the complex microbiome.
• Hands-On Learning and Workshops: The conference offers interactive workshops and skill-based sessions where participants can experience new diagnostic devices and therapeutic strategies first-hand. Practical, hands-on learning will help participants apply the most recent advances in their practice, translating science into real-world care.
• Networking and Collaboration Opportunities: Connect with healthcare experts, researchers, clinicians, and industry pioneers from around the globe. Build your network, exchange thoughts, and foster collaborations that might lead to research partnerships and innovative projects long after the event.
• Industry Exhibits and Technology Showcases: The exhibition space will host a few of the most innovative companies and technology providers in gastroenterology and hepatology. Participants can explore the most recent devices and products designed to improve diagnostics, streamline treatments, and improve patient outcomes.
• Professional Development and CME Credits: Earn Continuing Medical Education (CME) credits whereas expanding your skill. This conference allows you to meet your professional development goals in an environment focused on excellence and the most recent advancements in healthcare.
• Explore a Vibrant, Historical City: Held in Edinburgh, Scotland, this event offers an inspiring setting to interface with like-minded experts. Encounter the culture and history of Edinburgh, giving a culminate background for an improving instructive travel.

Who should attend

Healthcare Practitioners

-Gastroenterologists
-Hepatologists
-General Physicians
-Surgeons specializing in gastrointestinal and liver diseases
-Pediatric Gastroenterologists

Research and Academia

-Clinical Researchers in Gastroenterology and Hepatology
-Medical Scientists studying gut and liver diseases
-Professors and Lecturers in Gastroenterology
-Postdoctoral Fellows
-Medical Students and Trainees

Industry Professionals

-Pharmaceutical Researchers
-Biotechnology Experts
-Medical Device Developers
-Clinical Trial Coordinators
-Regulatory Affairs Specialists

Nursing and Allied Health Professionals

-Nurse Practitioners in Gastroenterology and Hepatology
-Dieticians and Nutritionists 
-Endoscopy Technicians
-Healthcare Administrators

Policy and Advocacy Groups

-Public Health Officials
-Healthcare Policy Makers
-Nonprofit Organizations focusing on digestive and liver diseases

Session/Tracks

Track1:Advancements in Non-invasive Liver Diagnostic

Track2:Microbiome and Gut Health

Track3:Hepatocellular Carcinoma (HCC): Early Detection and Management

Track4:Pediatric Gastroenterology and Hepatology

Track5:Colorectal Cancer: Early Detection, Diagnosis, and Therapeutics

Track6:Gut-Brain Connection in Gastroenterology

Track7:Precision medicine in gastroenterology

Track8:Advanced Techniques in Gastrointestinal Imaging

Track9:Translational Research in Gastroenterology and Hepatology

Track10:Immunotherapy in GI Cancer Treatment

Tracks11:Chronic liver disease management

Tracks12:Advanced Liver Regeneration and Stem Cell Research

Track13:Advances in Gut-Associated Lymphoid Tissue (GALT) and Immunity

Track14:AI in Early Diagnosis of Colorectal Cancer

Track15:Role of Artificial Intelligence in Clinical Decision Making

Track16:Advances in Endoscopic Techniques and Innovations

Track17:Microbiome and Its Impact on Colorectal Cancer (CRC)

Track18:Immunology and Genetic Mechanisms in Liver Transplantation

Track19:Genetic and Immunological Mechanisms in Autoimmune Gastrointestinal Disorders

Track20:Genetic Pathways in Non-Alcoholic Fatty Liver Disease (NAFLD) and NASH

Track21:CRISPR-Cas9 in Gastrointestinal and Hepatic Disease Research

Track22:Targeting Genetic Pathways in Gastrointestinal Inflammation

Track23:Genetic Markers for Predicting Inflammatory Responses in Liver Disease

Track24:Role of MicroRNAs in Genetic Regulation of Liver Diseases

Track25:Hepatitis D: The Silent Epidemic in Hepatology

Track26:Hepatitis E: Latest Updates and Research

Track27:Advances in Pancreatitis Treatment: Managing Acute and Chronic Cases

Track28:Obesity and Bariatric Surgery

Young Researcher Forum

The Young Researcher Forum at the 25th International Conference on Gastroenterology and Hepatology (June 4-5, 2025, Edinburgh, Scotland) offers an exciting opportunity for emerging researchers to engage with experts and showcase their innovative work in the field of gastroenterology and hepatology. For the YRF the participation criteria should be designed to encourage emerging talents while ensuring the quality and relevance of the research presented. Here’s a suggested framework for the criteria:

Eligibility Criteria:

Age Limit: Researchers should be under the age of 35 at the time of the conference (June 2025)

Academic/Professional Status:

-Researchers who are currently enrolled in or have recently completed a PhD, MD, or equivalent degree within the past 5 years.

-Medical residents or fellows actively involved in research.

-Research scientists, clinicians, or healthcare professionals working on innovative research related to gastroenterology and hepatology.

Research Experience: Candidates should have hands-on experience in research, particularly in areas such as:

-Gastrointestinal diseases (e.g., IBD, liver diseases, colorectal cancer).

-Hepatology (e.g., liver cirrhosis, viral hepatitis, liver transplantation).

-Innovations in diagnostic or therapeutic methods.

-Translational research or clinical applications of basic science.

Application Process:

Abstract Submission: Applicants must submit an abstract (maximum 500 words) that clearly outlines the objectives, methodology, results, and conclusions of their research.The abstract should highlight the innovative aspect of the research and its potential impact on patient care.It will be reviewed by a scientific committee for relevance, novelty, scientific rigor, and clarity.

Presentation Type: Applicants must choose whether they would like to present their research as:

-Oral Presentation: Short, high-impact presentations (10-15 minutes) to showcase research findings.

-Poster Presentation: Visual display of research findings with an opportunity for detailed discussion during dedicated poster sessions.

-Presentation Awards: Recognition for outstanding presentations, such as Best Oral Presentation and Best Poster Presentation, with certificates or prizes.

Participation Benefits

• Academic and Professional Growth

-Cutting-Edge Knowledge

-Expert Guidance

-Innovative Techniques

• Networking Opportunities

-Global Collaboration

-Mentorship and Peer Interaction

-Collaborative Research

• Recognition and Visibility

-Showcase Research

-Publication Opportunities

-Awards and Honors

• Skill Development

-Hands-On Workshops

-Interactive Panels

• Industry Interaction

-Market Trends

-Networking with Stakeholders

• Broader Impacts

-Global Health Contribution

-Personal Development

• Cultural and Experiential Benefits

-Explore Edinburgh

-CME Accreditation

Market Analysis

The field of gastroenterology and hepatology has experienced significant growth in both research and clinical advancements, driven by rising global prevalence of gastrointestinal (GI) and liver disorders, technological innovations, and increasing investments in healthcare. The market analysis below outlines key trends and dynamics that highlight the importance of this conference.

1. Prevalence of Gastrointestinal and Hepatological Disorders

Global Impact: Disorders such as inflammatory bowel disease (IBD), hepatitis, liver cirrhosis, and GI cancers affect millions globally. For instance, over 10 million people are diagnosed with IBD worldwide, and viral hepatitis remains a leading cause of liver cancer.

Rising Burden: Lifestyle changes, aging populations, and dietary habits contribute to the growing incidence of these diseases, emphasizing the need for innovative research and treatments.

2. Technological Advancements

Endoscopic Innovations: The development of advanced endoscopic techniques, including capsule endoscopy and AI-powered diagnostics, is revolutionizing the field.

Biomarker Development: Biomarkers for early detection and treatment monitoring are gaining traction in gastroenterology and hepatology.

Personalized Medicine: Advances in genomics and molecular research are paving the way for individualized therapies.

3. Market Trends

Global Market Size: The global gastroenterology devices market is projected to grow from USD 11 billion in 2022 to approximately USD 17 billion by 2030, with a CAGR of 5-6%.

Drug Development: Increased focus on biologics and small-molecule drugs for liver and GI disorders is driving growth in pharmaceuticals.

Healthcare Investments: Governments and private entities are investing in digestive and liver health research, boosting innovation.

4. Research and Collaboration Needs

Academic and Industry Collaboration: The need for bridging the gap between research and clinical practice is crucial, especially for transferring laboratory findings to patient care.

Interdisciplinary Research: Collaboration across fields like microbiome research, artificial intelligence, and immunotherapy is vital for advancing treatment paradigms.

5. Regional Focus

European Leadership: Europe remains a leader in gastroenterology research, with countries like the UK, Germany, and France hosting top research institutions and healthcare facilities. Edinburgh, as a hub for medical conferences, provides an ideal setting for knowledge exchange.

Global Participation: This conference offers opportunities for attendees to engage with international experts, enhancing collaborative potential.

Conclusion

The 25th International Conference on Gastroenterology and Hepatology aligns perfectly with market needs, addressing the latest trends in research, diagnostics, and therapeutics. It serves as a critical platform for stakeholders to exchange ideas, foster collaborations, and explore advancements in bridging research with patient care.